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ABSTRACT
Poly(ethyleneoxide)-poly(propyleneoxide)-poly(ethyl-
eneoxide) triblock copolymer (PEO-PPO-PEO) based
plasmid delivery systems are increasingly drawing
attention in the field of nonviral gene transfer
because of their proven in vivo transfection cap-
ability. They result from the simple association of
DNA molecules with uncharged polymers. We exam-
ined the physicochemical properties of PEO-PPO-
PEO/DNA mixtures, in which the PEO-PPO-PEO is
Lutrol  (PEO75-PPO30-PEO75), formulated under var-
ious conditions. We found that interactions between
PEO-PPO-PEO and DNA are mediated by the central
hydrophobic block within the block copolymer.
Dynamic light scattering and cryo-electron micro-
scopy showed that the mean diameter of transfecting
particles as well as their stability depended on the
PEO-PPO-PEO/DNA ratio and on the ionic composi-
tion of the formulating medium. The most active
formulation promoting a good tissue-distribution and
an optimal transfection was characterized by a
reduced electrophoretic mobility, a mean hydrody-
namic diameter of  250–300 nm and by a conserved
B-DNA form as shown by circular dichroism studies.
Our study also revealed that the stability of these
formulations strongly depended on a concentration
balance between the DNA and the PEO-PPO-PEO,
over which the DNA conformation was modified,
micron-sized particles were generated, and the
transgene expression was declined. We showed
that the physicochemical properties of PEO-PPO-
PEO/DNA formulations directly impact the level of
gene expression in transfected muscles.
INTRODUCTION
Nucleic acids based therapy is an attractive approach for the
treatment of several diseases (1–5). Although synthetic vector
based delivery systems are less efﬁcient than viral vectors
in vivo, they circumvent concerns of immunogenicity, virus-
mediated random integration and recombination with wild
type viruses (6,7). Among developed nonviral vectors, nonionic
block copolymers consisting of poly(ethyleneoxide)-poly-
(propyleneoxide)-poly(ethyleneoxide) triblocks (PEO-PPO-
PEO) hold promise as a novel class of carrier for in vivo
applications. Indeed, recent investigations have reported
that formulating DNA with given PEO-PPO-PEO allowed
for an increase in plasmid-mediated gene expression in var-
ious tissues including muscles, heart, lungs and eyes (8–13).
Nonionic PEO-PPO-PEO triblock copolymers belong to
poly(alkoxyde) family within which the largely studied
poly(ethyleneglycol) (PEG) has been reported to induce
signiﬁcant changes in DNA solubility and structure under
given conditions. Thus, DNA concentration, pH, ionic
strength of the medium and presence of divalent ions have
been shown to impact PEG-induced DNA precipitation
(14,15). The main explanation for this phenomenon has
been reported to be the change in the water activity induced
by the presence of PEG causing a reduction in DNA solubility.
In contrast to the water-soluble PEG homopolymer, PEO-
PPO-PEO bear amphiphilic properties due to the ability of the
lipophilic poly(propyleneoxide) (PPO) block to macroscopi-
cally phase-separate from water at relatively low temperature,
and to the high water solubility of the poly(ethyleneoxide)
(PEO) blocks. In an aqueous solution and at a given concen-
tration, PEO-PPO-PEO molecules remain as individual (non-
associated monomers) at temperatures below their critical
micellar temperature (CMT). Above the CMT the molecules
become more lipophilic leading to complex self-assembling
structures including micelles of various sizes, lyotropic liquid
crystalline gels and rod-like micelles (16,17). The PPO block
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factor in the formation of micelles that consist of a core of
PPO blocks and a corona of PEO blocks. Temperature, mole-
cular weight, concentration and presence of electrolytes are
known to affect the phase behavior of PEO-PPO-PEO in solu-
tion. For example, the micelle formation is greatly inﬂuenced
by the addition of electrolytes shifting the CMT to lower tem-
peratures (18–20). These differences in structure and property
taken together with the very high transfection efﬁciency of
PEO-PPO-PEO prompted us to investigate the physicochem-
ical properties of PEO-PPO-PEO/DNA formulations. In pre-
vious studies, hydrodynamic diameter and zeta potential have
been used to characterize formulation made of DNA and F68
(9). Despite this, little is known about the physicochemical
aspects that govern the association of the negatively charged
polyelectrolyte that is DNA, with these self-organizing nonio-
nic amphiphilic block copolymers. An understanding of those
properties is needed to establish a correlation between
physicochemical properties of PEO-PPO-PEO/DNA formula-
tions and their transfection efﬁciency. Thus, this study was
designed (i) to deﬁne the experimental conditions that lead
to better association of DNA with PEO-PPO-PEO; (ii) to
track the features of PEO-PPO-PEO/DNA formulations that
promote high gene transfer efﬁciency in vivo; (iii) to investi-
gate whether PEO-PPO-PEO/DNA formulations follow
molar ratio law currently used in cationic vector based formu-
lations. To conduct our investigations, Lutrol  was taken as a
model compound of PEO-PPO-PEO because of its low levels
of toxicity in muscle (21).
MATERIALS AND METHODS
Plasmids
pCMV-Luc (22) and pCIK CAT (generous gift of D. Gill,
Oxford)areplasmidsencodingluciferaseandchloramphenicol
acetyl transferase (CAT) reporter genes, respectively, both
under the control of the human cytomegalovirus immediate-
early gene promoter. They were puriﬁed from recombinant
E.coli by means of EndoFree plasmid puriﬁcation columns
(Qiagen, Chatsworth, CA).
Formulation preparation
Lutrol  (EO75-PO30-EO75, MW 8600), F38 (EO75-PO15-
EO75, MW 4700), F108 (EO75-PO65-EO75, MW 14600) and
F127 (EO15-PO50-EO75, MW 12600) were gifts from
BASF. Poly(ethyleneoxide), PEG (EO77, MW 8000) were
from Sigma-Aldrich. Stock solutions of polymers were
prepared at given weight-to-weight (w/w) concentration in
sterilized water and were kept at 4 C overnight to ensure
complete dissolution. Formulations of DNA with polymers
were prepared by equivolumetric mixing of polymer at var-
ious concentrations in water with the desired concentration
of DNA dissolved in saline 2· or in Tyrode 2·.
Mean diameter and zeta potential measurements
Hydrodynamic mean diameter, given as mean diameter,
and zeta potential of the DNA alone or the DNA within
polymer/DNA formulations were assessed using a Zetasizer
3000HSA apparatus (Malvern Instruments, Orsay, France).
Hydrodynamic mean diameter was determined by dynamic
light scattering using the intensity mean size (Z Average)
with a sample refractive index of 1.59, viscosity of 0.89 cP.
The system was routinely calibrated using a 220 nm standard
dts 5050 from Malvern. Mean diameters values correspond to
the average of 10 independent measurements performed on
the same sample and calculated using the cumulant analysis
mode. The zeta potential measurement based on Laser
Doppler interferometry was used to assess the electrophoretic
mobility of DNA, either naked or associated with polymers.
Measurements were performed for 20 s using a standard
capillary electrophoresis cell with zero ﬁeld correction. The
dielectric constant was 79 and the Smoluchowsky constant
F(ka) was 1.50. The system was routinely calibrated using
a  50 ± 5 mV standard (Malvern). For polymer and DNA
concentration-dependent zeta potential, DNA was formulated
with polymers at desired concentrations in saline or in
Tyrode. Samples were then submitted to zeta potential
measurement at 25 C. For the temperature-dependent zeta
potential study, 100 mg DNA/ml was formulated with 0.35,
1.15 and 1.75 mM Lutrol . Samples were injected in the
capillary cell and the temperature was adjusted via the peltier
controller unit adapted to the apparatus. After reaching the
desired temperature, the system was stabilized for 10 min
before performing measurements.
Circular dichroism
Circular dichroic (CD) spectra of the DNA alone or the DNA
within formulations were obtained on a JASCO spectropolari-
meter (model J-810, JASCO, Tokyo, Japan) using a 1 cm path
length quartz cuvette in saline or Tyrode. Final DNA concen-
tration within the formulations was 25 mg/ml in both media.
The ellipticity values are given in millidegrees (mdeg) with
the values for saline or Tyrode subtracted from the experi-
mental values of the corresponding formulation or DNA
alone.
Cryo-TEM micrography
Formulation complexes were prepared at 100 mg DNA/ml
and various PEG or Lutrol  concentrations either in saline
or in Tyrode. Five microliters sample were deposited onto a
holey carbon coated copper grid; the excess was blotted with
a ﬁlter paper, and the grid was plunged into a liquid ethane
bath cooled with liquid nitrogen (Leica EM CPC). Specimens
were maintained at a temperature of approximately  170 C,
using a cryo holder (Gatan), and were observed with a FEI
Tecnai F20 electron microscope operating at 200 kV and at
a nominal magniﬁcation of 50000· under low-dose condi-
tions. Images were recorded with a 2K · 2K Gatan slow
scan CCD camera.
In vivo transfection
Female Swiss mice were obtained at 8 weeks of age from
Janvier (Le Genest Saint Isle, France). Following anaesthesia
with hypnomidate (40 mg/kg, intraperitoneal), 50 mlo f
formulation in saline or in Tyrode, were injected into shaved
tibialis anterior muscles at one site, using a microﬁne syringe
with a small 30 gauge needle (U100; Becton Dickinson,
Sandy, UT). Injections were performed parallel to the muscle
ﬁbers. At least six tibialis anterior muscles were included in
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values are the average of ﬁve and two independent experi-
ments for luciferase and CAT expression, respectively.
Seven and three days after injection of luciferase and CAT
reporter gene, respectively, muscles were dissected and
snap-frozen in liquid nitrogen. The muscles were homoge-
nized in 1 ml of luciferase reporter lysis buffer (Promega,
Madison, WI) or CAT reporter lysis buffer (Roche Diagnos-
tic, Mannheim, Germany) both supplemented with a protease
inhibitor cocktail (Roche Diagnostics). Samples were then
centrifuged at 10000 r.p.m. for 5 min. Luciferase activity
was measured from a 10 ml aliquot of supernatant with
VICTOR2 (PerkinElmer, Les Ulis, France), using a luciferase
assay system (Promega) based on light emission after addi-
tion of 100 ml of luciferase assay substrate. Each muscle
extract was analyzed in duplicate. A standard curve, prepared
with non-injected mouse tibial anterior muscle, was included
with each microplate reading, using a puriﬁed luciferase
(Sigma, St. Louis, MO). CAT activity was measured from
diluted aliquots of supernatant with VICTOR2 using the
CAT Elisa kit (Roche Diagnostics) following instructions of
the supplier. Each muscle extract was analyzed in duplicate.
A standard curve, prepared in standard sample buffer (Roche
Diagnostics), was included on each microplate using the
CAT enzyme standard included in the kit. To study the inﬂu-
ence of cardiotoxin and hyaluronidase on gene transfection
efﬁciency, 4 mg of cardiotoxine (Latoxan, Valence, France)
and 1 unit of hyaluronidase (Sanoﬁ-synthelabo, Le Plessi
Robinson, France) were injected intramuscularly 5 days and
3 h prior to formulation injections, respectively.
Fluorescence microscopy
pCMV-Luc was Rhodamine-labelled by nick translation
according to the supplier protocol (Molecular Probes). Mice
were injected with formulations made of 100 mg/ml of the
labelled DNA with or without 3.5 mM Lutrol  and sacriﬁced
12-h after injection. Immediately after euthanasia of mice,
tibial anterior muscles were harvested and ﬁxed in 4% parafor-
maldehyde for 10 min. They were then embedded in Tissue-
Tek and snap-frozen in liquid nitrogen cooled in isopentane.
Thick sections (8 mm) were cut from the entire muscle and
reviewed under a Zeiss AxioVision ﬂuorescence microscope.
RESULTS
Characterization of Lutrol /DNA formulations
in saline
Compared to PEG, which is a polymer of ethyleneoxide units,
Lutrol  consists of a succession of 30 propyleneoxide moi-
eties ﬂanked on both sides by 75 ethyleneoxide moieties.
We ﬁrst investigated whether the presence of the central
PPO block within Lutrol  could impact DNA light scattering
property by using a PEG of about the same number of alkox-
yde as control. For this purpose, since PEO-PPO-PEO
alone, but not PEG, can be subject to self-light scattering
at high concentrations, DNA was formulated in saline at
10 mg/ml with low subscattering Lutrol  concentrations
(0.11–0.35 mM). The results were compared with those
obtained from the corresponding PEG made formulations.
As showed in Figure 1A, the scattered light intensity in
Lutrol /DNA formulations increased as the Lutrol  concen-
tration was raised, while in PEG made formulations, the scat-
tered light intensity did not change. In the absence of DNA,
both polymers exhibited very low and similar light scattering
patterns. This observation showed that the presence of
Lutrol  changed the light scattering property of the DNA
or that new molecular species may be generated in the pre-
sence of Lutrol , but not in the presence of PEG. To check
the meaning of these characteristic changes from the view-
point of DNA hydrodynamic diameter, quasi-elastic light
scattering (QELS) studies were performed under the same
conditions. Results were expressed as global mean diameter
of particles scattering in solution. As showed in Figure 1B,
cumulant mode analysis of QELS data revealed that increas-
ing the Lutrol  amount led to a steep decrease in the mean
diameter of DNA from 400 to  225 nm. Such a reduction
in DNA hydrodynamic diameter did not occur in PEG/
DNA formulations at low concentration of polymer
(Figure 1C). However, raising both polymer amounts to
Lutrol  scattering range concentrations (1.1–10.5 mM)
allowed for further mean diameter reduction in both formula-
tions (Figure 1B and C). We also noted that particles within
Lutrol /DNA formulations were smaller than those in PEG/
DNA formulations.
For further characterization, we then compared both
type of formulations by studying the electrophoretic mobility
of DNA, expressed as the zeta potential. The zeta potential
increased as the Lutrol  concentration was raised, reaching
above the neutrality at 7.0 mM Lutrol . In contrast increasing
PEG concentration did not lead to a zeta potential reduction
(Figure 1D). To further understand the importance and
the role of the PPO block in the observed DNA mobility
reduction, we measured the zeta potential of formulations
prepared with a PEO-PPO-PEO with the same percentage
of ethyleneoxide (80%) as Lutrol , but two-times less
(F38) and two-times more (F108) propyleneoxide moieties.
The zeta potential reduction did not occur for F38/DNA
formulations even at 7.0 mM polymer ( 19.0 mV), while it
was faster with F108/DNA formulations; at 1.1 mM
(Figure 1E). Furthermore we investigated the zeta potential
of formulations made of F127 which bears about the
same amount of polypropylene moiety as F108 but 70% of
ethyleneoxide. The results showed that the zeta potential
reduction occurred at lowest polymer concentrations
(Figure 1E). We thus found a hydrophobicity dependence
on the DNA mobility reduction that strongly suggested a
PPO block-dependent interaction between the DNA and
PEO-PPO-PEO copolymers.
Effect of physiological mimicking medium on
Lutrol /DNA physicochemical properties
Tyrode’s solution (Tyrode) has been described as a
physiological medium that mimics the extracellular ionic
composition and consequently the ionic environment of
Lutrol /DNA formulation after in vivo delivery. Since both
DNA and PEO-PPO-PEO intrinsic properties depend upon
their concentration and upon the nature and the concentra-
tions of ions in solution, we compared the physicochemical
properties of Lutrol /DNA formulations made in Tyrode
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increase in the DNA amount to a concentration compatible
with luciferase assay following an intramuscular injection
(100 mg/ml of DNA). Results showed that, at a low concen-
tration of DNA (10 mg/ml), particles within formulations
shared the same mean diameter as the polymer concentration
increased irrespective of the medium used (Figure 2A). In
contrast, when using 100 mg/ml of DNA, particle mean
diameter was minimum at 0.35 mM Lutrol , then increased
progressively when the Lutrol  concentration increased
(Figure 2A). Interestingly, in Tyrode, while at 10 mg/ml of
DNA particle sizes were similar to overall Lutrol  concentra-
tions, at 100 mg/ml of DNA and 10.5 mM Lutrol  particles
appeared as 1.1 mm aggregates (Figure 2A). Moreover,
while from 0.35 to 7.0 mM Lutrol , particle mean diameters
were similar in both media, the increase in zeta potential
occurred more quickly in Tyrode, reaching a maximum of
–7.0 mV at 3.5 mM Lutrol . This increase in zeta potential
was signiﬁcantly slower in saline ( 25 mV at 3.5 mM
Lutrol ). The zeta potential did not change with increasing
the PEG concentration in control PEG/DNA formulation
with 100 mg/ml DNA (Figure 2B).
Figure 1. Characterization of polymer/DNA formulations in saline. Formulations containing increasing amount of triblock copolymers or PEG were prepared in
saline at the final DNA concentration of 10 mg/ml and submitted to dynamic light scattering analysis by using a ZetaSizer 3000HSA. (A) Change in scattered
light intensity from Lutrol - (closed squares) and PEG-(open squares) made formulations with (solid lines) or without (dashed lines) plasmid DNA as a function
of polymer concentration. (B) Mean diameter of particles within Lutrol /DNA formulations as a function of Lutrol  concentration. Polydispersity indexes (PI):
*PI ¼ 0.4–0.5, **PI ¼ 0.3–0.5, #PI ¼ 0.6–0.7. (C) Mean diameter of particles within PEG/DNA formulations as a function of polymer concentration. (D) zeta
potential of Lutrol /DNA (closed squares) and PEG/DNA (open squares) formulations as a function of polymer concentration. (E) zeta potential of formulations
made of F38, F108 and F127 at various concentrations of each polymer.
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To check if micrography of formulations could be in agree-
ment with the observed changes in particle hydrodynamic dia-
meter, Cryo-TEM micrography was performed. Structures
were analyzed at the reliable concentrations of 0.35, 3.5
and 10.5 mM Lutrol  or PEG using 100 mg/ml of DNA. At
0.35 and 3.5 mM Lutrol , no condensed DNA structures
were observed both in saline and in Tyrode (data not
shown).At10.5 mMLutrol ,globular features of100–200 nm
in size with a very low contrast were visible in saline
(Figure 3A–F), while micron-sized large compact DNA
structures with a round-shaped feature were observed in
Tyrode (Figure 3G–J). At a higher magniﬁcation, DNA
molecules appeared condensed within these structures
(Figure 3B–F and H–J). Although DNA molecules are tightly
packed, they did not exhibit regular pattern like lamellar
or hexagonal packing described with cationic lipids
(23–28). However, linear features were visible on the edge
of the condensates, likely revealing a rough linear organiza-
tion of DNA strands. In the middle of the condensates, no
peculiar pattern was observed probably because of the
thickness increase.
Figure 2. Characterization of Lutrol /DNA formulations in Tyrode’s solution. (A) DNA was formulated at 10 mg/ml (open bars) or 100 mg/ml (closed bars) in
both saline and Tyrode with increasing amounts of Lutrol . Formulations were then submitted to mean diameter measurement using the zetasizer 3000HSA.
Polydispersity indexes (PI): *PI ¼ 0.4–0.5, **PI ¼ 0.3–0.5, #PI ¼ 0.6–0.7. (B) DNA was formulated at 100 mg/ml with Lutrol  in saline (filled squares) or
Tyrode (closed triangles) or with PEG (open circles) in Tyrode, zeta potential of the formulations were measured by using the Zetasizer 3000HSA.
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condensed DNA even at lowest polymer concentrations.
Figure 3K and L–M shows representative structures obtained
at 3.5 and 10.5 mM PEG, respectively. These DNA conden-
sates resemble a small dense core surrounded by ﬁne
elongated structures (Figure 3M). Their size did not change
signiﬁcantly while increasing PEG concentration. These
results showed that Lutrol  and PEG triggered the condensa-
tion of DNA molecule in a notably different manner. With
PEG, DNA condensation occurred at a lower concentration
and the global shape and size of these condensed structures
remained unchanged even at high PEG concentration. With
Lutrol , condensed DNA structures were formed only at
high polymer concentration and their shape were very differ-
ent from those formed with PEG. Such compact structures
were never observed with DNA alone either in saline or in
Tyrode (data not shown). With Lutrol, compact and dense
structures were formed while with PEG DNA was condensed
into expanded and branched structures. If the morphologies
of the condensates were different, the DNA organization
induced in the presence of Lutrol  and PEG looked similar.
This non-regular DNA condensation induced by PEG
has already been reported with linear DNA (29). The pre-
sence of propylene oxide moiety plays a crucial role in the
morphology of the DNA condensed structure.
Circular dichroism of Lutrol /DNA formulations
To investigate whether this ﬁrst set of data, including
cryo-TEM observations, had any signiﬁcance on the molecu-
lar organization of the DNA within the formulations, circular
dichroism studies were performed at 0.35, 3.5 and 10.5 mM
Lutrol  or PEG. No change in the DNA spectrum was
observed for PEG made formulations either in saline or in
Tyrode regardless of the presence and the concentration of
the polymer (data not shown). In saline, at all Lutrol 
concentrations, the typical spectrum of DNA B-form with a
negative band at 245 nm and a positive band at 272 nm
was obtained with both polymers (Figure 4A) (30,31). Simi-
larly, the DNA spectrum did not change for Lutrol  made
formulations at 0.35 and 3.5 mM in Tyrode (Figure 4B).
However, at 10.5 mM Lutrol , changes in both the negative
and the positive peaks of DNA occurred with shifts to 250
and 288 nm, respectively (Figure 4B). Such shifts indicate
a transition of the secondary DNA structure from a B- to a
C-type. Moreover, simultaneous decrease in the positive
peak and the increase in the negative peak were observed
(Figure 4B). The decrease of the positive value has been
explained by dehydration and/or neutralization of the phos-
phate group and might thereby indicate difference in hydra-
tion state of DNA either free or associated with Lutrol .
The increase in the negative peak of the DNA spectra
suggested the presence of DNA helices oriented parallel to
each other in the condensed DNA, called the Y-form of
DNA (32–34).
Study of hydrophobicity mediated Lutrol /DNA
interaction
Based on the zeta potential reduction as a function of PEO-
PPO-PEO concentrations and PPO block length and also on
the absence of zeta potential reduction in the presence of
PEG, we hypothesized that DNA and PEO-PPO-PEO interact
through the central hydrophobic PPO arm leading to the zeta
potential reduction. By changing artiﬁcially the hydrophobi-
city of Lutrol  molecules, we should thus be able to show
Figure 3. Cryo-TEM micrographs of formulations. Lutrol /DNA and PEG/DNA formulations containing 100 mg/ml of DNA were visualized by cryo-electron
microscopy. (A) Field of view of 10.5 mM Lutrol  made formulation in saline, (B–F) showing representative samples of structures observed at high
magnification. (G) Field of view of 10.5 mM Lutrol  made formulation in Tyrode, (H–J) showing representative samples of aggregates encountered at higher
magnification. (K) Fields of view of formulations 3.5 mM PEG made formulation in Tyrode; (L) and (M) are fields of view of 10.5 mM PEG made formulations
in Tyrode at low and high magnification, respectively
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phosphate groups and Lutrol  at lowest concentrations.
Temperature-induced hydrophobicity was used to argue our
hypothesis. Experiments were performed at 1.75 mM Lutrol
and T<55 C, conditions under which the scattered light inten-
sity of the Lutrol  did not change while the temperature
increased. Formulations were then prepared at various
concentrations of DNA and Lutrol  and zeta potential was
measured as a function of the temperature. Figure 5A showed
that at a ﬁxed DNA concentration of 100 mg/ml, 0.35 and
1.16 mM Lutrol  did not induce zeta potential increase
from 15 to 45 C, while a moderate increase occurred between
45 and 55 C. At 1.75 mM Lutrol , such temperature-induced
zeta potential increase occurred earlier, between 25 and 35 C
(from  24 to  7.0 mV). Further temperature increase did not
affect the zeta potential value. Zeta potential of PEG/DNA
control formulation did not change with increasing the tem-
perature (Figure 5A). Figure 5B showed that at the given
Lutrol  concentration of 1.75 mM, a 3-fold increase in
DNA amount (300 mg/ml of DNA) delayed the temperature-
induced zeta potential neutralization observed previously.
Furthermore, a 10-fold reduction of DNA amount
(10 mg/ml) did not allow highly negative zeta potential
values. These results demonstrated a strong impact of the
polymer hydrophobicity on the DNA mobility reduction
and also the importance of the concentration balance between
the DNA and the polymer on this phenomenon.
Reporter gene expression and tissue-distribution
To gain insight into the relationship between the transfection
potential of formulations and their aforementioned physico-
chemical properties, they were injected into mice tibial
anterior muscles. In saline, the presence of 3.5 mM Lutrol 
increased luciferase activity by a factor 10 over that of
naked DNA while no signiﬁcant increase was observed
with 0.35 mM. Increasing the Lutrol  concentration to
10.5 mM led to a decrease in luciferase expression to levels
lower than that obtained with naked DNA (Figure 6). In
Tyrode, the same concentration/luciferase activity pattern
was observed, excepted that luciferase activity was higher
Figure 4. Circular dichroism spectra of Lutrol /DNA formulations. Formulations were prepared at 25 mg/ml of DNA with 0.35 mM (circles), 3.5 mM (squares)
and 10.5 mM (triangles) of Lutrol  either in (A) saline or (B) Tyrode. Non-formulated DNA (opened circle) in saline or in Tyrode was used as control. Spectra
were recorded on a JASCO-810 spectropolarimeter.
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Figure 5. Study of hydrophobicity mediated Lutrol /DNA interaction.
(A) Formulations were prepared in Tyrode, at a final DNA concentration of
100 mg/ml with 0.35 mM (closed circles), 1.16 mM (closed squares) and
1.75 mM (closed triangles) of Lutrol  or 1.75 mM PEG (open diamonds).
(B) Formulations were prepared with 1.75 mM Lutrol  at the final DNA
concentration of 0 (open diamonds), 10 mg/ml (closed circles), 100 mg/ml
(closed triangles), 300 mg/ml (closed diamonds). Temperature was raised and
the zeta potential was measured by allowing 10 min equilibration between
each temperature.
734 Nucleic Acids Research, 2007, Vol. 35, No. 3than in saline (Figure 6). Luciferase expression was 2- and
18-fold higher with 0.35 and 3.5 mM, respectively, as com-
pared with naked DNA. Such a spectacular improvement in
DNA-mediated luciferase expression was not observed for
PEG at the optimal concentration of 3.5 mM or for other
tested concentrations (Figure 6). To better understand the
main reason underlying such an improved transgene expres-
sion, muscles were injected with 100 mg/ml of rhodamine-
labelled DNA alone or formulated with 3.5 mM Lutrol .
As shown in Figure 7, naked DNA molecules were poorly
distributed in the muscle and were mainly located around
the injection site (Figure 7A). The presence of Lutrol 
ensured an even spread of the DNA throughout the muscle
with ﬂuorescent spots observed in numerous muscle ﬁbers
(Figure 7B). As control, muscle injection with non-labelled
molecules, did not show ﬂuorescence (data not shown).
We then investigated whether the observed improved
transgene expression was only due to a better tissue-
distribution allowing an increase in the number of transfected
ﬁbers. Cardiotoxin and hyaluronidase, which have been
reported to improve naked DNA-based transgene expression
in muscle, were injected prior to formulation injections. In
contrast to naked DNA, both cardiotoxin and hyaluronidase
injection failed to increase the transfection efﬁciency of
Lutrol /DNA formulations, suggesting that the important
reduction of the DNA charge achieved by formulating the
DNA with Lutrol  leads to a different type of mechanism
that contribute to the better DNA uptake by the ﬁbers.
Study of Lutrol /DNA formulation stoichiometry
The results described above showed that for 100 mg/ml of
DNA, raising the Lutrol  concentration to 10.5 mM triggered
micron-sized aggregates formation and reduced the transfec-
tion efﬁciency. As a reﬂex of nonviral system formulators, we
thought that varying amount of polymer and DNA by keeping
constant Lutrol /DNA ratio could overcome aggregate for-
mation and then prevent the loss in transgene expression.
We then varied DNA concentrations from 10 to 1000 mg/ml
in Tyrode within 0.35, 3.5, 7.0 and 10.5 mM Lutrol  in order
to study the stoichiometry impact on the formulation. For this
purpose we used a CAT encoding DNA since CAT activity
detection Kit is more sensitive than luciferase assay.
Figure 8A shows that, at 0.35 mM Lutrol , there was no sig-
niﬁcant variation in size with increased DNA amount and that
at 3.5 and 7.0 mM Lutrol ,  500 nm sized particles were
generated for DNA concentrations >100 mg/ml. Surprisingly,
increasing the amount of DNA in 10.5 mM made formula-
tions did not impair nor reduce aggregates formation as
would be excepted, but generated larger aggregates for high-
est DNA concentrations. Formulations made with 0.35 mM
Lutrol had zeta potentials that sharply decreased as the
DNA concentration was raised (Figure 8B). At 3.5 mM
Lutrol , formulations had a zeta potential close to neutrality
for DNA concentration ranging from 5 to 100 mg/ml, and for
higher DNA concentrations, the zeta potential decreased and
stabilized around  17 mV (Figure 8B). The results obtained
at 7.0 mM Lutrol  were similar to those obtained at 3.5 mM
(data not shown).
Finally, we evaluated the inﬂuence of DNA concentration
on transfection efﬁciency. Injection of Lutrol /DNA formula-
tions led to a signiﬁcant increase in CAT expression when the
amount of formulated DNA increased up to 50 mg/ml.
A further increase in the amount of DNA led to a plateau
of gene expression. Most importantly, naked DNA led to a
maximum gene expression with 300 mg DNA/ml, whereas
Figure 6. Reporter gene expression in mouse tibial anterior muscle.
Lutrol /DNA formulations were prepared at 100 mg/ml of DNA in saline
or Tyrode in the absence (open bar) or in the presence of 0.35 mM (hashed
bar), 3.5 mM (closed bars) and 10.5 mM (dotted bars) of Lutrol . PEG/DNA
formulations were prepared at 100 mg/ml of DNA in Tyrode with 3.5 mM
(closed bars) and 10.5 mM (dotted bars) of PEG. An aliquot of 50 ml of each
formulation (corresponding to 5 mg of DNA) were injected per tibial anterior
muscle. Reporter gene expression was monitored 7 days after injection. Each
column represents the mean ± SEM of at least 10 individual values.
Figure 7. Tissue-distribution and intracellular matrix role study Representa-
tive views of muscle sections injected with (A)5mg of Rhodamine-labelled
DNA alone or (B) formulated with 3.5 mM Lutrol .( C) Cardiotoxin and/or
Hyaluronidase were injected in muscle prior to either naked DNA or Lutrol /
DNA injection. Reporter gene expression was monitored 7 days after
injection. Each column represents the mean ± SEM.
Nucleic Acids Research, 2007, Vol. 35, No. 3 735with Lutrol  the same expression level was achieved with
10–20 mg DNA/ml (Figure 8C). Expressing the results as
the ratio of CAT activity obtained from Lutrol /DNA
complexes versus that obtained from naked DNA, showed
that the maximum increase in CAT expression over naked
DNA was observed with 50 and 100 mg DNA/ml
(Figure 8C, inset).
DISCUSSION
In this article, we have investigated the physicochemical
properties of the new promising nonviral system resulting
from the association of DNA molecules with nonionic
amphiphilic block copolymers. We attempted to understand
the key parameters involved in the association of both mole-
cules and the behavior of the DNA within the formulation.
Thereby we aimed to draw correlations between their
physicochemical properties and their transfection efﬁciency,
which is of crucial importance for the development of
nonviral vectors. In our previous works, we have reported
that mixing DNA with PE6400 block copolymer or Lutrol 
increased either reporter and therapeutic genes expression
in skeletal or cardiac muscles and in lungs, including
the corresponding pathological tissues such as Duchenne
Muscular Distrophy muscles and cystic ﬁbrosis lungs
(10,12,13). Proofs of PEO-PPO-PEO-based formulations
effectiveness have also been reported by Lemieux et al.
(8) who have used mixture of L61 and F127 to transfect
muscle. More recently P85 was reported to successfully
increase transfection in muscle (35). Similarly, F68/DNA
formulations have been shown to efﬁciently transfect
eyes by drop delivery (9). So far no thorough
investigations have been done to characterize this type of
formulations and to study the relationships between the
formulation features, the transfection efﬁciency and the
tissue-distribution of the DNA following intramuscular
injection.
Figure 8. Study of Lutrol /DNA formulation stoichiometry (A) Lutrol /DNA formulations were prepared with 0.35 mM (closed circles), 3.5 mM (closed
diamonds), 7.0 mM (closed squares) and 10.5 (closed triangles) of Lutrol  and increasing amount of DNA in Tyrode. Mean diameters were measured on the
zetasizer 3000HSA. Polydispersity indexes (PI): *PI ¼ 0.4–0.5, **PI ¼ 0.3–0.5, #PI ¼ 0.6–0.7, ##PI ¼ 0.7–0.8. (B) Lutrol /DNA formulations were prepared
with 0.35 mM (filled triangle) and 3.5 mM (filled diamond) of Lutrol  and increasing amount of DNA in Tyrode. Zeta potential were measured on the zetasizer
3000HSA. (C) Lutrol /DNA formulations were prepared with 3.5 mM Lutrol  (closed bars) and various concentrations of DNA. Equivalent amounts of naked
DNA (open bars) were used as control. A constant 50 ml volume was injected per tibial anterior muscle. (inset) Each bar represents the ratio of CAT activity
obtained with Lutrol /DNA complexes divided by the CAT activity of naked DNA.
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showed that the presence of the PPO arm in a nonionic PEO-
PPO-PEO copolymer may markedly modify both electrical
and hydrodynamic properties of DNA in solution when
compared to PEG homopolymer. We also showed that by
opposition to PEG, PEO-PPO-PEO were able to interact
with DNA in a concentration-dependent manner and that
this interaction was signiﬁcantly increased in a physiological
mimicking medium such as Tyrode. We demonstrated that
the interaction between DNA and PEO-PPO-PEO was
mediated by the hydrophobic POP block. This is shown by
the difference in zeta potential reduction while using PEO-
PPO-PEO containing shorter or longer size of PPO block
and by the temperature-induced zeta potential reduction.
We noticed that the polymer concentrations under which
the maximum zeta potential reduction was obtained did not
correspond to their CMC (36). We have also found that,
although the ion types contained in Tyrode allowed a better
interaction of Lutrol  with DNA, such ionic composition
can favor formation of aggregated DNA forms when
using higher PEO-PPO-PEO amount. Generated aggregates
failed to improve in vivo gene expression. On the other
hand, at lower PEO-PPO-PEO concentration, the transfection
efﬁciency was declined. Thus, we have evidenced an optimal
3.5 mM Lutrol  concentration, under or over which the trans-
fection efﬁciency was lost. However, when the formulation
balance is reached, Tyrode made formulation displayed
higher transfection efﬁciency. The difference in ionic compo-
sition between saline and Tyrode plays probably a central role
in improving transgene expression. The presence of divalent
cations such as calcium and magnesium as well as the
buffered feature of Tyrode may also contribute positively to
the plasmid delivery into the cells. Previous works using
others PEO-PPO-PEO block copolymers have shown that a
mixture of L61 and F127 (8) or P85 alone (35) led to an
increase in reporter gene expression by a factor 10 or 15 as
compared to naked DNA, respectively. In the same experi-
mental conditions, i.e. 5 mg of DNA per muscle and 7 days
post-injection, Lutrol  can lead to up to 36-fold increase in
transgene expression (12). Compared to our previous data
in which PE6400 (PEO13-PPO30-PEO13) was used (10), the
present results suggest that the intrinsic hydrophilic–
hydrophobic balance is a key parameter in selecting such
polymers for efﬁcient intramuscular gene expression. Never-
theless, we previously reported only a 2-fold increase in
transgene expression in a dystrophic mouse model (mdx)
(12). Thus the nature of the muscle inﬂuences the efﬁciency
of PEO-PPO-PEO mediated gene expression.
Due to the absence of charged atoms on PEO-PPO-PEO
block copolymers, it was difﬁcult to imagine an interaction
between the DNA and these uncharged polymers. However,
it has been demonstrated elsewhere that uncharged polyvinyl
pyrrolidone (PVP) polymer can interact with DNA, creating a
hydrophobic surface that protects the DNA from degradation
and increases interaction with cell membranes (37,38). In
contrast to PVP that has hydrophobic and hydrophilic sites
located together along the same molecule, block copolymer
structure allows a clearly distinct and separated localization
of hydrophobic and hydrophilic segments. Then, the good
colloidal stability of PEO-PPO-PEO/DNA formulations,
even though the particles exhibit neutral zeta potential,
could be due to the presence of a hydrated outer corona
made of PEO blocks. Supramolecular organization of PEO-
PPO-PPO/DNA clearly contrasts with that obtained with non-
viral complexes resulting from the association of DNA with
cationic molecules, where neutral complexes formation led
to colloidally unstable formulation and then to aggregated
complexes (23,39). Previous structural studies of cationic
polymers and lipids based complexes have shown a pro-
nounced change in DNA CD spectrum with a y-DNA form
(40,41). The results obtained here suggest that the lack of
transfection efﬁciency of cationic systems following intra-
muscular injection may be caused by this important change
in the DNA molecular structure. Indeed, as shown by the
DNA CD spectrum of a 10.5 mM Lutrol  made formulation,
aB -t oY-DNA form change occurred and Lutrol /DNA for-
mulation failed to increase the transgene expression, whereas
at the optimal 3.5 mM Lutrol  concentration, the native
B-DNA form was maintained. Thus, unmodiﬁed non-
aggregated DNA structure, neutrally charged formulation
seem to be the sine qua none conditions required for PEO-
PPO-PEO block copolymers mediated transgene expression
improvement. Our results indicate that the optimal feature
of active PEO-PPO-PEO/DNA, and Lutrol /DNA formula-
tions in particular, is an interactive non-condensing asso-
ciated complex. This feature is in agreement with the absence
ofdecreaseinethidiumbromideﬂuorescenceinthepresenceof
3.5 or 7.0 mM Lutrol  (data not shown). Another important
contrasting feature that belongs to PEO-PPO-PEO/DNA
made complexes is the weak interaction force between the
DNA and the PEO-PPO-PEO shown by the lack of retardation
of the DNA in the presence of the copolymer while using
agarose gel retardation assay (data not shown). This weak
interaction force could favor fast release and/or increased
availability of the DNA once the formulation is injected.
Moreover, the present results showed that the PEO-PPO-
PEO/DNA concentration ratio directly impacted the level of
gene expression in vivo. Indeed, increasing Lutrol  amount
over the ideal Lutrol /DNA ratio led to the formation of
large aggregates, probably responsible for the decrease in
the transfection efﬁciency due to a poor diffusion. It then
appeared that, decreasing this optimized ratio by increasing
the DNA concentration allowed the formation of negatively
charged formulations. In these conditions, negative charges
of DNA were not sufﬁciently masked and large aggregates
were formed. The beneﬁt due to the presence of the carrier
is lost in that circumstance, as shown by the reduction of
the ratio of formulated/naked DNA transgene expression.
When compared with naked DNA, formulated DNA is
greatly spread in the muscle after injection. This suggests
that, shielding the negative charge of DNA affects its interac-
tion with the negatively charged extracellular matrix plasma
membrane allowing an improved tissue-distribution of the
DNA as shown by the even ﬂuorescence in Lutrol /
Rhodamine-labelled DNA injected muscles. The shielding
may facilitate the DNA cellular uptake by decreasing the
electrostatic repulsion. Putative receptors present in the intact
extracellular matrix may be involved in the Lutrol /DNA
complex uptake by a mechanism different from that impli-
cated in naked DNA internalization. Then, the assembled
Lutrol /DNA complex interacting with the plasma membrane
could be directly delivered to the cytosol via diffusion
Nucleic Acids Research, 2007, Vol. 35, No. 3 737through the plasma membrane or by endosome from where
they may efﬁciently escaped. In both hypothetical cases the
presence of amphiphilic PEO-PPO-PEO may play a central
role. It has been indeed reported that PEO-PPO-PEO block
copolymers have the ability to perturb the plasma membrane
byinsertionintotheacylchainportionofthelipidbilayers(42).
Another important ﬁnding of this study is that, overcoming
high-concentrations induced DNA aggregation was not possi-
ble by balancing the Lutrol  amount with the appropriate
DNA concentrations, a procedure that can be used in cationic
carriers based formulations. PEO-PPO-PEO block copoly-
mers seem to have a completely different feature that does
not follow the basic rule of stoichiometric ratio. In conclu-
sion, we have drawn out three physicochemical formulation
zones. An electronegative, small and stable particles zone
generated by  0.35 mM Lutrol  that failed to increase trans-
fection efﬁciency; an electroneutral, small and stable particle
zone triggered by 3.5 and 7.0 mM Lutrol  where particles
transfect efﬁciently; and an electroneutral and aggregated
particles zone obtained at 10.5 mM Lutrol  in which the
transfection efﬁciency is lost. A recent study on the concen-
tration effect showing the decline in transgene expression at
concentrations higher or lower than the optimal dose has
been found with P85, and strongly supports our ﬁnding (35).
This study provides a better understanding of nonionic
PEO-PPO-PEO/DNA complexes formation and their impact
on in vivo transfection efﬁciency. Future experiments will
aim to extend this study to other PEO-PPO-PEO family mem-
bers in order to deﬁne a structure–activity relationship
between structurally different PEO-PPO-PEO. This
structure–activity relationship will be used to design novel
block copolymers that lead to enhanced gene expression in
various organs.
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